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Abstract
Here we present in situ observations of adsorption of bovine serum albumin (BSA) on citrate-
stabilized gold nanospheres. We implemented scattering correlation spectroscopy as a tool to
quantify changes in the nanoparticle Brownian motion resulting from BSA adsorption onto the
nanoparticle surface. Protein binding was observed as an increase in the nanoparticle
hydrodynamic radius. Our results indicate the formation of a protein monolayer at similar albumin
concentrations as those found in human blood. Additionally, by monitoring the frequency and
intensity of individual scattering events caused by single gold nanoparticles passing the
observation volume, we found that BSA did not induce colloidal aggregation, a relevant result
from the toxicological viewpoint. Moreover, to elucidate the thermodynamics of the gold
nanoparticle-BSA association, we measured an adsorption isotherm which was best described by
an anti-cooperative binding model. The number of binding sites based on this model was
consistent with a BSA monolayer in its native state. In contrast, experiments using poly-ethylene
glycol capped gold nanoparticles revealed no evidence for adsorption of BSA.
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1. Introduction
The safe use of nanoparticles in in vivo applications requires a clear understanding of the
nanoparticle interface.1–3 How nanoparticles diffuse and interact with biomolecules in
complex biological fluids is an intriguing question that receives growing attention.4–6 For
instance, the interaction of nanoparticles with blood plasma is of special interest7–9 because
many of their intended biomedical applications (e.g. drug delivery,10–12 disease diagnosis
and treatment13–17) often require an intravenous approach.
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Recent studies have demonstrated that once nanoparticles are introduced into plasma they
can become coated by the vast collection of biomolecules present in this medium, forming a
‘corona’ that surrounds the nanoparticles and shields their original surface properties.18–20
Serum proteins play a major role in these interactions because they constitute the majority of
the plasma fluid and have comparable nano-scale sizes.21 It is thought that the affinity of a
certain protein to bind to a nanoparticle surface is determined by the nanoparticle size,22,23
shape,24 and surface chemistry.22,24
The role of a corona masking the designed surface chemistry of nanoparticles is a critical
issue as cellular uptake and its associated physiological response are regulated by chemical
interactions at the nanoparticle surface.21,25 Doorley et al.26 demonstrated the co-
localization of 200 nm polysterene beads and serum albumin, the most abundant protein in
human blood,27 at the membrane of kidney cells. This has the subtle yet critical implication
that what the cell actually ‘sees’ is not the nanoparticle core or the initially synthesized
organic interface but the bound proteins forming a corona on the nanoparticle surface. A
recent report by Deng et al. 28 showed how 5 and 20 nm poly-acrylic acid coated gold
nanoparticles bound to and induced unfolding of fibrinogen, thereby exposing a specific
amino acid combination that interacts with an important receptor on human leukemia cells
causing the release of cytokines and hence inflammation. Such protein-nanoparticle hybrids
could show long term stability under in vivo conditions and trigger undesired signals in
cellular receptors that would otherwise remain inactive. The necessary knowledge of these
unwanted side effects encourages fundamental research on the characterization of the
nanoparticle interface when exposed to physiological environments.
Nanoparticle-protein associations have been characterized by several different methods that
typically require the separation of the nanoparticles from the adsorbed proteins, followed by
the identification of the isolated organic compounds.29 A common approach involves
isolation via size exclusion chromatography or differential centrifugation, followed by
protein identification via gel electrophoresis and mass spectrometry.30 Deposition of a dried
sample on a substrate has been useful for structural imaging via transmission electron
microscopy, while the identification of the protein corona is done by staining of the organic
compounds.8 Most strategies therefore involve the removal of the nanoparticle-protein
complexes from their original physiological environments.21
A complimentary in situ approach to these previous studies measures diffusion parameters
before and after protein adsorption.31 This allows one to address such important issues as
the amount of adsorbed protein and the fate of the nanoparticle-protein complexes directly in
physiological environments. The latter is especially critical from a toxicological viewpoint if
adsorbed proteins induce nanoparticle aggregation,32 which may complicate cellular uptake
and clearance, or if nanoparticles induce protein aggregation,33 which is often associated
with a variety of diseases. Therefore, in situ observations of protein adsorption on
nanoparticles under physiological conditions are required for the safe development of the
emerging field of nanomedicine.
Gold nanoparticles (AuNPs) have emerged as a favorable platform for potential applications
in nanomedicine because of the established non-toxicity of the gold core.34 Furthermore
AuNPs are attractive because their strong plasmon resonance makes it possible to
simultaneously use them as optical probes.35–37 However, in situ characterization of AuNPs
interacting with proteins are scarce and, to some extent, contradicting as both
monolayer19,31 and multilayer20,24 adsorption of serum albumin have been reported for
AuNPs in a physiological environment. Additionally, disagreement exists in the literature on
whether BSA stabilizes the NP colloid19,31,38 or induces NP aggregation20,24. The
mechanism for BSA adsorption on negatively charged citrate-stabilized AuNPs is also under
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debate. Both an electrostatic attraction via the positively charged lysine groups of BSA19,38
and a ligand exchange reaction with the sulfur of the cysteine residue that binds to the AuNP
surface31 have been suggested. Because nanoparticle-protein interactions and the possible
formation of a protein corona are thought to depend on many parameters including
nanoparticle size and shape as well as surface chemistry, further quantitative in situ
measurements are necessary.
Here, we use plasmon scattering correlation spectroscopy39 to explore in situ protein
adsorption on AuNPs by monitoring the changes in the Brownian diffusion due to protein
binding. Bovine serum albumin (BSA) was used a model protein and shares almost identical
structure, function, and pH-dependent transitions with its human counterpart.27,40 Our
results indicate the formation of a BSA monolayer at blood plasma concentrations on citrate-
stabilized AuNPs independent of AuNP size in the range of 51 – 93 nm. Citrate-stabilized
AuNPs were used because they are the most common spherical AuNPs used. Burst intensity
frequency analysis (BIFA)41 of scattering transients furthermore reveals that BSA
adsorption does not induce colloid aggregation for these AuNPs. Based on the results of an
adsorption isotherm, we demonstrate that BSA adsorption occurs spontaneously via an anti-
cooperative binding mechanism. Finally, experiments with poly-ethylene glycol (PEG)
functionalized AuNPs show that the PEG coating provides protection from BSA adsorption.
2. Experimental Section
2.1 Materials
Citrate-stabilized AuNPs with three distinct diameters (51, 70, and 93 nm) and 56 nm
AuNPs capped with PEG (MW = 5,000) were purchased from Nanopartz Inc. BSA (≥98%
lyophilized powder, MW = 66,430) was obtained from Sigma-Aldrich Corp. The purity of
the protein was comparable to previous nanoparticle studies.18–20,24,31,38 Contamination by
small molecules can be neglected as they do not cause a measurable effect in the correlation
spectroscopy measurements. The protein powder was suspended and diluted to the desired
concentration (0.75 mM unless noted otherwise) in 25 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES buffer, Life Technologies™), 20 mM NaCl (Sigma-
Aldrich) and Ultrapure™ molecular biology grade water (Gibco). The BSA solutions were
freshly prepared for each experiment, or otherwise stored at −20 °C to reduce protein
aggregation and sedimentation. The pH of this solution was in the physiological range (7.0 –
7.5). The AuNPs were also diluted in this buffer to picomolar concentrations (~1010
particles/mL). For protein binding experiments, AuNP and BSA solutions were mixed using
equal volumes and then measured immediately. Microscope cover glass slides (25 × 25
mm2, Fisherbrand) were sonicated in acetone (ACS spectrophotometric grade, Sigma-
Aldrich), 1% Liquinox™ (Alconox Inc.), and Milli DI™ water (>25 MΩ, Millipore) followed
by drying with ultra high purity N2 (Matheson) and O2 plasma cleaning for 1 minute at 300
mTorr (Harrick Plasma). To avoid unwanted protein adsorption to the substrate, the cover
glass was treated with Vectabond reagent (Vector Labs) and PEG-5000 (Sigma-Aldrich)
following a procedure described elsewhere.42 Silicon chambers (50 μL, Grace Bio-Labs)
were placed on top of the microscope coverslips and filled with the solution of interest.
2.2 AuNP Characterization
The AuNPs were characterized using transmission electron microscopy (TEM, JEOL 2010)
and ensemble UV/Vis spectroscopy (Ocean Optics) as shown in Figure 1 and in the
supporting information (Figures S1 and S2). The size distribution of each sample was
obtained from the TEM images using an automated Matlab program. Two perpendicular
axes were measured per AuNP and the results are summarized in Table S1. The AuNPs
were mostly spherical as indicated by the black dashed lines in Figures 1A and S1. Zeta
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potentials were measured for AuNPs only and AuNPs with BSA added using a Malvern Zen
3600 (Zetasizer Nano). The samples were prepared in the same way as described above. The
Smoluchowski approximation (F(Ka) = 1.5) was used as an input parameter of the Henry
equation, corresponding to the electrophoretic mobility of small particles in aqueous media.
2.3 Optical Setup for Scattering Correlation Spectroscopy
Scattering correlation spectroscopy was performed using a home-built inverted confocal
microscope (Observer. D1, Zeiss). Briefly, light from a 532 nm laser (Verdi-6, Coherent
Inc.) was collimated and expanded to overfill the back aperture of a microscope objective
(Fluar, Zeiss: 100X, N.A. = 1.3). The beam was circularly polarized using a λ/4 waveplate
(Newport). The laser power was attenuated to ~ 150 nW using neutral density filters
(Thorlabs). This power gave a signal to background ratio of ~ 10, yet ensured negligible
heating of the sample.39 The focal plane of the objective was set to approximately ~ 6 μm
inside the solution to avoid excessive scattered light from the glass-water interface. Orange
fluorescent polystyrene beads (100 nm in diameter, Molecular Probes®) were used for
alignment and calibration of the focal volume (Figure S3). AuNPs diffusing across this
diffraction limited focal volume scattered light due to their inherent surface plasmon
resonance. Plasmon scattering was chosen for these experiments instead of one-photon
plasmon luminescence of the AuNPs39 because of an interfering background signal from
auto-fluorescence by the BSA solution. For the scattering geometry, fluorescence was
negligible at the excitation powers used (Figure S4). The scattered light was collected in the
backwards direction and redirected to a 50 μm pinhole (Thorlabs) before focusing onto an
avalanche photodetector (SPCM-AQRH, Perkin Elmer).
2.4 Analysis of Scattering Correlation Spectroscopy
Correlation spectroscopy yields the characteristic diffusion time τD of an analyte of interest
as it diffuses through a diffraction limited focal volume. Due to the low concentrations used
(typically < nM), it is assumed that only one analyte crossed the focal volume (< 1 fL) at a
time. Fluctuations in the scattering intensity I(t) were observed when AuNPs were optically
excited while diffusing across this focal volume. Temporal autocorrelation analysis of the
scattering signal was performed over a range of lag times τ from τmin to τmax:43
(1)
Here G(τ) represents the autocorrelation function and δI(t) an intensity fluctuation, which is
mathematically represented as the signal at time t minus the average: δI(t) = I(t) − <I(t)>.
For the case of a Gaussian excitation profile, Aragon et al.44 derived the three dimensional
autocorrelation function in terms of the average number of species crossing the focal volume
<N>, the beam waist r0, and beam height z0:
(2)
The experimental autocorrelation was fitted to equation (2), where τD and  were used as
fit parameters. The amplitude was normalized for better comparison of the differences in τD
associated with BSA binding. The characteristic diffusion time is related to the translational
diffusion coefficient Dtr by the following relationship:43
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(3)
The Stokes-Einstein equation then yields the hydrodynamic radius Rh:
(4)
Where k is the Bolztmann constant, T is the temperature (T = 296 ± 0.5 K), and η is the
solvent viscosity. The effect of BSA on the viscosity of the solution was considered using a
linear approximation based on the intrinsic viscosity of the protein provided by the
manufacturer, [η] = 4.13 cm3 g−1. The procedure to calibrate r0 and how it affects the
experimental error in our correlation spectroscopy experiments can be found in the
supporting information (Figure S3).
The minimum and maximum lag times were set to τmin = 10 μs and τmax = 40 s,
respectively. This ensured reproducibility and accuracy in the analysis for all AuNP sizes
studied here, according to the guidelines for correlation spectroscopy published
previously.45 We further tested that the value chosen for τmax was indeed adequate for the
AuNP concentrations used. Figure S5A and Table S2 show the experimental Rh for 51 nm
AuNPs as a function of τmax for a constant total collection time of 300 s. Rh converges to
the value expected from TEM imaging (horizontal dashed line) for τmax = 20 s. 40 s
intensity transients therefore gave correct values for Rh. In fact, for picomolar AuNP
concentrations a single 40 s transients contained enough events to accurately determine Rh.
This is illustrated in Figure S5B, which shows the experimental Rh retrieved from 40 s
intensity transients as a function AuNP concentration expressed in terms of number of
events Nevents. The minimum number of events required per individual transient was ~ 20
for the 51 nm AuNPs. If Nevents was less than this value, Rh was severely underestimated
when compared to the size distribution obtained via TEM (red dashed lines). To avoid this
artifact, the AuNP concentration was always kept in the picomolar regime, which
guaranteed that at least 100 events were sampled per 40 s transients.
3. Results and Discussion
Citrate-stabilized AuNPs interacted with BSA, the most abundant protein in the circulatory
system, at concentrations similar to those found for albumin in human blood (~ 0.75 mM).
The normalized UV/Vis extinction spectrum of 51 nm citrate-stabilized AuNPs in Figure 1B
(solid blue line) shows a strong surface plasmon resonance peak at 534 nm. The plasmon
resonance maximum red-shifted by ~ 3 nm after the AuNPs were mixed with a 0.75 mM
BSA solution (dashed red line). Similarly, the UV/Vis extinction spectra of citrate-stabilized
70 and 93 nm AuNPs red-shifted by 2 ~ 3 nm in the presence of BSA, as shown in Figures
S2A and S2B, respectively. This suggests that BSA interacted with citrate-stabilized AuNPs
and caused a change in the refractive index at the AuNP surface and consequently a shift of
the plasmon resonance energy. To establish that BSA indeed binds to citrate-stabilized
AuNPs, quantify the amount of adsorbed protein, and to check if protein adsorption leads to
AuNP aggregation we performed in situ equilibrium binding experiments using scattering
correlation spectroscopy in combination with analysis of the intensity transients by BIFA.
The characteristic diffusion time of AuNPs increased in the presence of BSA. Figure 2A
shows the average of 56 autocorrelation curves (τmax = 40 s each) of 51 nm AuNPs before
and after mixing with BSA at physiological concentrations. By combining equations (3) and
(4), the increase in τD can be related to the change in Rh, which is found to be ΔRh = 4.6 ±
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1.9 nm (Figure 2A inset; see the supporting information for the calculation of the
experimental error). Because BSA in its native (N) state can be approximated as a triangular
equilateral prism with sides of 8 × 8 nm2 and a height of 3.4 nm,27 the increase in Rh
corresponds to no more than monolayer adsorption of BSA bound to the AuNP surface with
the triangular base. This is consistent with previous experiments investigating the adsorption
of human (and bovine) serum albumin on the surfaces of AuNPs19,31 and semiconductor
nanoparticles.18 The small discrepancy between the change in Rh and the BSA dimensions
reported by x-ray crystallography27 could be due to a solvent hydration shell and the
heterogeneous AuNP size distribution.
BSA adsorption was independent of AuNP size as illustrated in Figures 2B and 2C, which
show the same monolayer adsorption for 70 and 93 nm AuNPs, respectively. The
characteristic diffusion times and diffusion constants for all three AuNPs samples with and
without BSA as measured via scattering correlation spectroscopy are summarized in Table
1. The hydrodynamic radii Rh are also given. The values for the AuNP-BSA system were
corrected for the change in viscosity when adding the BSA solution. Ignoring the
contribution of the citrate capping layer, the sizes obtained by scattering correlation
spectroscopy are in excellent agreement with those measured by TEM.
It is important to establish whether the change in Rh is indeed due to BSA adsorption or
because of the formation of a small number of aggregates. Correlation spectroscopy is in
principle an ensemble measurement technique and therefore it is difficult to exclude based
on only the autocorrelation curves in Figure 2 that the increase in diffusion times was caused
by the presence of a few larger AuNP aggregates instead of the formation of a BSA
monolayer.18 The fact that the change in Rh is the same for all three samples suggests that
aggregation is not a dominant factor though. To further verify this, we analyzed the
individual 40 s intensity transients by autocorrelation analysis independently instead of
averaging them together as was done for Figure 2, because the formation of rare, large
aggregates would cause a broad distribution of Rh values. This allowed us to access the
distribution of Rh and analyze any changes in size heterogeneities associated with protein
binding. The resulting histograms for Rh without and with BSA are shown in Figures 3A
and 3B for the 51 nm AuNPs, respectively. The distribution of Rh from 56 individual 40 s
intensity transients for the AuNPs only (Figure 3A) shows a Gaussian profile consistent with
the size distribution observed via TEM and lacks a trailing tail of large Rh values that would
be expected if aggregates were present. Figure S6 confirms that this is also the case for the
Rh distribution of 70 and 93 nm AuNPs. More details regarding the analysis and an
autocorrelation of a representative 40 s intensity trace (Figure S7) can be found in the
supporting information.
Further evidence for the absence of AuNP aggregation and the formation of a BSA
monolayer on citrate-stabilized AuNPs under physiological conditions was obtained by
BIFA of individual events in the intensity transients (Figure 4). The number of events
Nevents counted per 40 s intensity transient, a good estimate of the average number of
AuNPs sampled, is nearly identical for the AuNP and AuNP-BSA samples. Figure 4A
shows an intensity histogram of individual bursts for the representative time transient given
in the inset. The corresponding data for 51 nm AuNPs after addition of BSA is given in
Figure 4B. No significant reduction in the number of events was observed. In addition,
because the scattering intensity scales as ~ d6 for AuNPs with diameters d < 100 nm,46,47
the presence of aggregates with significantly larger scattering intensities would be evident in
the intensity distribution. However, neither a decrease in the number of events nor a change
in the intensity histograms towards higher values was observed, confirming that the stability
of the colloid is preserved after protein adsorption. This is also the case for the 70 and 93 nm
AuNPs samples, as shown in Figure 4C, where the average number <Nevents> of events per
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40 seconds is presented for at least 30 time transients per sample. The small decrease in
<Nevents> is within the experimental uncertainty and can be explained by the increase in the
viscosity due to the presence of BSA. After aggregation has now been ruled out, we further
quantified BSA-AuNP binding.
The adsorption isotherm for 51 nm AuNPs was found to follow an anti-cooperative binding
model reaching saturation at physiological concentrations. This was achieved by
constructing an adsorption isotherm over a wide range of BSA concentrations. Figure 5
shows the experimental Rh as a function of BSA concentration (red squares). Following the
approach by Rocker et al.18 for adsorption of human serum albumin on smaller FePt and
CdSe/ZnS nanoparticles, the experimental data is fitted to a modified Langmuir model given
in equation (5):
(5)
Here VBSA and VNP are the volumes of the BSA and the AuNP, respectively, N is the
number of proteins bound, KD is the dissociation constant, and n is the Hill coefficient,
which measures the cooperativity of the binding. A Hill coefficient of n = 0.4 ± 0.1 and a
dissociation constant of KD = 256 ± 50 μM returned the best fit (dashed blue line). A Hill
coefficient smaller than 1 indicates anti-cooperative binding and implies strong repulsion
between bound and free BSA molecules, that increases as more surface binding sites are
filled. This furthermore predicts that adsorption beyond a monolayer is negligible, in
agreement with the results in Figure 2. For comparison, the traditional Langmuir model with
n = 1 is based on the assumption that binding occurs independent of surface coverage and
results in a steeper increase of Rh as a function of BSA concentration, as illustrated by the
dashed black line in Figure 5. The dissociation constant corresponding to the Langmuir
model is therefore an order of magnitude lower (KD = 20 ± 10 μM). While a Langmuir
adsorption isotherm was reported for BSA binding to citrate-capped gold films,38 more
recent studies on nanoparticles also show an anti-cooperative binding model.18,20,24 This
difference between a nanoparticle and a film surface is presumably due to the limited
number of binding sites and the surface curvature for a nanoparticle.
Knowing both n and KD from the measured isotherm we can extract further information for
BSA binding to AuNPs. First, the fit with n = 0.4 ± 0.1 yields N = 295 ± 30 proteins bound
to the surface of the 51 nm AuNPs. The theoretically available number of binding sites for a
monolayer coverage on a 51 nm AuNP is estimated to be ~ 250 by dividing the surface area
of the AuNP (S = 4 * π * 25.5 nm2 = 8171.3 nm2) by the triangular cross section of the
folded BSA (1/2 * 8 * 8 nm2 = 32 nm2). This excellent agreement gives additional
confirmation for the adsorption of a monolayer of BSA in its native (N) state on citrate-
capped AuNPs. Denaturation from the N-state to a partially unfolded (F) state (N-F
transition)48 after adsorption cannot be ruled out though, but all of our experiments suggest
that spreading of BSA on the surface of the AuNPs is unlikely, in agreement with previous
studies on AuNPs and semiconductor nanoparticles.18,19,24,31 Second, using KD we can also
calculate the free energy of adsorption ΔG0 according to:49
(6)
Dominguez-Medina et al. Page 7
Langmuir. Author manuscript; available in PMC 2013 June 19.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
where R is the gas constant and K is the binding constant, which is obtained as the inverse of
KD. Equation 6 yields ΔG0 = −4.9 kcal/mol for the anti-cooperative binding model,
indicating a spontaneous process for the binding of BSA to the AuNPs.
Finally, we investigated PEG-coated AuNPs as PEG has been commonly used to prevent
protein adsorption to surfaces.50,51 We indeed found no significantly adsorption of BSA on
PEG-coated AuNPs. Figure 6A shows UV/Vis extinction spectra of 56 nm PEG-
functionalized AuNPs before and after addition of BSA under the same experimental
conditions as for the citrate-stabilized AuNPs. No shift in the plasmon resonance maximum
was observed, in contrast to the citrate-stabilized AuNPs. The autocorrelation curves
presented in Figure 6B also did not show an increase in the characteristic diffusion time, and
therefore the relative change in the AuNP Rh due to BSA adsorption is negligible. A protein
monolayer therefore did not form on top of the PEG-coated AuNPs.
However, we cannot rule out sub-monolayer formation due to electrostatic interactions,
hydrophobicity, or van der Waals forces of a few BSA molecules with the PEG-coated
AuNPs. Future experiments will test this scenario, with fluorescence correlation
spectroscopy using dye-labeled BSA.
BSA is a globular protein and consists of 583 amino acids, 60 of which are lysine residues,
17 disulphide bridges, a single tryptophan, and a free thiol (cysteine-34).27 It has been
proposed that BSA adsorption on citrate-capped gold surfaces could be either due to an
electrostatic attraction with the positively charged lysine residues,19,38 or by a thiol ligand
displacement reaction through the unpaired cysteine.31 In particular, Brewer et al. compared
BSA adsorption on bare and citrate- coated flat gold surfaces using a quartz crystal
microbalance and interpreted the higher binding constant for citrate-coated surfaces as an
electrostatic attraction mechanism.38 Casals et al. reached the same conclusion based on the
observation that for small 4 nm negatively charged AuNPs formation of a protein corona
was slow, which they argued was inconsistent with a ligand replacement reaction because
smaller nanoparticles should have better access to the exposed thiol.19 In contrast, Tsai et al.
suggest a ligand exchange reaction on citrate-stabilized AuNPs via the thiol-terminated
cysteine residue based on the binding constants obtained from adsorption isotherms.31
Because of the small size of the citrate molecules it is not possible to distinguish between
ligand replacement and binding on top of the citrate stabilizing layer by correlation
spectroscopy. We also measured the zeta potential of the citrate-capped AuNPs before and
after addition of BSA. Figure S8 shows that the surface potential of the AuNPs became less
negative due to BSA adsorption, consistent with an electrostatic binding mechanism via the
positively charged lysine residues. However, replacing the negatively charged citrate
molecules with BSA is expected to have a similar effect because BSA is also overall
negatively charged at physiological pH.40 Furthermore, we note that many surface
functionalization procedures of the same citrate-capped AuNPs involve the initial
replacement of the citrate, which is used for the AuNP growth, with especially sulfur
terminated ligands.52 In the case of the PEG-coated AuNPs, the zeta potential measurements
showed that the AuNPs are only slightly negatively charged (Figure S8). Following the
electrostatic binding mechanism, this reduction in surface charge could therefore explain the
absence of BSA adsorption. It should be pointed out though that because the length of the
PEG molecules is about 5 nm for a fully stretched conformation and therefore comparable
with the height of the BSA, the correlation spectroscopy measurements presented here make
it difficult to distinguish between no BSA adsorption and a thiol-thiol exchange reaction.
However, as the PEG is also bound via a sulfur group to the AuNP surface the latter
scenario is rather unlikely as the free energy for the replacement of one thiol with another
one has been determined to be ΔG0 ~ +30 kcal/mol in the case of self-assembled
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monolayers on flat gold surfaces.53 Further experiments with different surface charges and
chemistries are planned to obtain a more complete picture and to establish the role of
different adsorption mechanisms with distinct effects on the biological activity. Significant
more insight into the adsorption mechanism at the nano-bio interface can be obtained by
labeling the protein and possibly the ligands with dye molecules and performing multi-color
(excitation and detection) auto- and cross-correlation spectroscopy.
4. Conclusions
We have shown in situ evidence for adsorption of BSA on citrate-stabilized AuNPs. UV/Vis
extinction spectroscopy revealed a red-shift in the surface plasmon resonance for the citrate-
stabilized AuNPs. Quantitative analysis of the diffusion parameters before and after protein
adsorption showed an increase in the AuNP hydrodynamic radius. The change in
hydrodynamic radius corresponds to the formation of a BSA monolayer independent of
AuNP size for diameters ranging between 51 and 93 nm. Combining correlation
spectroscopy with BIFA, we furthermore demonstrated that protein adsorption does not lead
to AuNP aggregation. An adsorption isotherm showed that the association of BSA to citrate-
stabilized AuNPs can be described by an anti-cooperative binding model, which yielded a
number of bound protein molecules in agreement with the estimated number of binding sites
based on the equilateral base of N-state BSA and the AuNP surface area. These results are in
good agreement with previous in situ measurements of smaller 10 nm citrate-stabilized
AuNPs interacting with BSA, studied by dynamic light scattering.19 Furthermore, we
demonstrated that BSA adsorption is negligible on PEG-coated AuNPs. Although the
system studied here was specific - BSA interacting with citrate-stabilized AuNPs, the in situ
approach using correlation spectroscopy and BIFA presented here can be directly applied to
other nanoparticle-protein interactions.
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Figure 1.
(A)Size distribution of 51 nm AuNPs obtained by TEM. The dashed black line represents an
aspect ratio of 1, or perfect spherical shape. (B) Normalized UV/Vis ensemble extinction
spectra of 51 nm AuNPs before (solid, blue) and after (dashed, red) mixing with BSA at
0.75 mM. The lower left inset contains a representative TEM image of the sample. The
upper right inset zooms into the region of the surface plasmon resonance maximum λmax.
Dominguez-Medina et al. Page 13
Langmuir. Author manuscript; available in PMC 2013 June 19.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Autocorrelation curves of AuNPs and AuNPs + BSA [0.75 mM], for three AuNPs samples
with mean diameters of 51 nm (A), 70 nm (B) and 93 nm (C). The amplitude of the
autocorrelation is normalized to 1 for better comparison of the characteristic diffusion time,
τD. The average hydrodynamic radius <Rh> obtained from the autocorrelation curves is
shown as squares in the insets. The expected increase in Rh due to BSA binding is 3.4 nm
per layer (dashed lines). The error bars represent the experimental uncertainty of three to
five independent measurements.
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Figure 3.
Distribution of Rh obtained by autocorrelation analysis of individual 40 s intensity
transients. The width of the histrogram bars corresponds to the error in Rh calculated with
equation S6 for an individual transient. The error quoted in the figure is the standard
deviation of the distribution.
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Figure 4.
Blip intensity frequency analysis (BIFA) of 51 nm AuNPs before (A) and after (B) binding
to BSA [0.75 mM]. The events are counted based on 40 s intensity transients displayed in
the insets. (C) Average number of events before (blue) and after (red) binding to BSA for
the three AuNP sizes measured. The error bars represent one standard deviation from the
average value.
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Figure 5.
Adsorption isotherm relating the concentration of BSA with the nanoparticle Rh (red
squares). The data is fitted to the Langmuir model given by equation 5. A Hill coefficient n
of 0.4 returns the best fit (blue line). A comparison to a non-cooperative binding model (n =
1) is shown by the black line.
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Figure 6.
(A) Normalized UV/VIS extinction spectra of 56 nm PEG-coated AuNPs before (solid green
line) and after (dashed red line) addition of BSA. The inset zooms into the region of λmax.
(B) Autocorrelation curves of 56 nm PEG-coated AuNPs before (green) and after (red)
addition of BSA. The inset shows the average hydrodynamic radius <Rh> obtained from
autocorrelation analysis. For comparison, the expected increase in Rh based on one layer of
BSA is shown by the dashed red line.
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